Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Blinkenberg

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Neurological Disorders|January 21, 2016
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospectsPer Soelberg Sorensen, Morten Blinkenberg
CNS Drugs|March 13, 2017
Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage AgentsMorten Blinkenberg, Per Soelberg Sørensen
CNS Drugs|January 30, 2020
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple SclerosisFinn Sellebjerg, Morten Blinkenberg, Per Soelberg Sorensen
Danish Medical Journal|May 13, 2014
Onset symptoms in paediatric multiple sclerosisMagnus Spangsberg Boesen, Finn Sellebjerg, Morten Blinkenberg
Clinical Nuclear Medicine|June 14, 2023
Comparison of Translocator Protein Expression Between Tumefactive Multiple Sclerosis and GlioblastomaPer Jensen, Morten Blinkenberg, Lars Hageman Pinborg
Ugeskrift for Laeger|September 21, 2019
[Autologous haematopoietic stem cell transplantation of patients with multiple sclerosis]Freja Jespersen, Anne Fischer-Nielsen, Søren Lykke Petersen, et al.
Multiple Sclerosis and Related Disorders|July 21, 2022
Oligoclonal bands, age 11-17 years, occipital lesion, and female sex differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort studyMagnus Spangsberg Boesen, Annika Reynberg Langkilde, Jurgita Ilginiene, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2020
School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational studyMagnus Spangsberg Boesen, Morten Blinkenberg, Lau Caspar Thygesen, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort studyTine Iskov Kopp, Morten Blinkenberg, Thor Petersen, et al.
Multiple Sclerosis and Related Disorders|December 23, 2021
Validation of MRI radiological reports in pediatric MS according to the McDonald 2017 criteria: A Danish nationwide multicenter cohort studyMagnus Spangsberg Boesen, Annika Reynberg Langkilde, Jurgita Ilginiene, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Neurological Disorders|January 21, 2016
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospectsPer Soelberg Sorensen, Morten Blinkenberg
CNS Drugs|March 13, 2017
Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage AgentsMorten Blinkenberg, Per Soelberg Sørensen
CNS Drugs|January 30, 2020
Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple SclerosisFinn Sellebjerg, Morten Blinkenberg, Per Soelberg Sorensen
Danish Medical Journal|May 13, 2014
Onset symptoms in paediatric multiple sclerosisMagnus Spangsberg Boesen, Finn Sellebjerg, Morten Blinkenberg
Clinical Nuclear Medicine|June 14, 2023
Comparison of Translocator Protein Expression Between Tumefactive Multiple Sclerosis and GlioblastomaPer Jensen, Morten Blinkenberg, Lars Hageman Pinborg
Ugeskrift for Laeger|September 21, 2019
[Autologous haematopoietic stem cell transplantation of patients with multiple sclerosis]Freja Jespersen, Anne Fischer-Nielsen, Søren Lykke Petersen, et al.
Multiple Sclerosis and Related Disorders|July 21, 2022
Oligoclonal bands, age 11-17 years, occipital lesion, and female sex differentiate pediatric multiple sclerosis from acute disseminated encephalomyelitis: A nationwide cohort studyMagnus Spangsberg Boesen, Annika Reynberg Langkilde, Jurgita Ilginiene, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2020
School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational studyMagnus Spangsberg Boesen, Morten Blinkenberg, Lau Caspar Thygesen, et al.
Multiple Sclerosis and Related Disorders|February 3, 2020
Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort studyTine Iskov Kopp, Morten Blinkenberg, Thor Petersen, et al.
Multiple Sclerosis and Related Disorders|December 23, 2021
Validation of MRI radiological reports in pediatric MS according to the McDonald 2017 criteria: A Danish nationwide multicenter cohort studyMagnus Spangsberg Boesen, Annika Reynberg Langkilde, Jurgita Ilginiene, et al.
Pageof 5